Den Europæiske Union - dansk - EMA (European Medicines Agency)

boehringer ingelheim international gmbh - tenecteplase - myokardieinfarkt - antitrombotiske midler - metalyse er indiceret til trombolytisk behandling af mistanke om myokardieinfarkt med vedvarende st elevation eller seneste venstre-bundle-gren blok inden for seks timer efter symptomdebut akut-myokardie-infarkt.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

astrazeneca ab - reassortant influenzavirus (levende svækket) af følgende stamme: a / vietnam / 1203/2004 (h5n1) stamme - influenza, human - vacciner - profylakse af influenza i en officielt erklæret pandemisk situation hos børn og unge fra 12 måneder til under 18 år. pandemic influenza vaccine h5n1 astrazeneca bør anvendes i overensstemmelse med officielle retningslinjer.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

kite pharma eu b.v. - axicabtagene ciloleucel - lymphoma, follicular; lymphoma, large b-cell, diffuse - antineoplastiske midler - yescarta is indicated for the treatment of adult patients with diffuse large b cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl) that relapses within 12 months from completion of, or is refractory to, first-line chemoimmunotherapy. yescarta is indicated for the treatment of adult patients with relapsed or refractory (r/r) dlbcl and primary mediastinal large b cell lymphoma (pmbcl), after two or more lines of systemic therapy. yescarta is indicated for the treatment of adult patients with r/r follicular lymphoma (fl) after three or more lines of systemic therapy.

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

glaxosmithkline pharma a/s - influenzavirus a/california/07/2009 (h1n1) - deriveret stamme fra nymc x-181, influenzavirus a/perth/16/2009 (h3n2) lignende stamme (a/victoria/210/2009 nymc x-187 reassortant), influenzavirus b/brisbane/60/2008, split virioner, inaktiveret - injektionsvæske, suspension, fyldt injektionssprøjte

Den Europæiske Union - dansk - EMA (European Medicines Agency)

kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - lymfom, mantelcelle - antineoplastiske midler - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

eurocept international b.v. - tobramycinsulfat - injektionsvæske, opløsning - 40 mg/ml

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

accord healthcare b.v. - cytarabin - injektions-/infusionsvæske, opløsning - 100 mg/ml

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

accord healthcare b.v. - cytarabin - injektions-/infusionsvæske, opløsning - 20 mg/ml

Den Europæiske Union - dansk - EMA (European Medicines Agency)

sanofi b.v. - agalsidase beta - fabry disease - andre alimentary tract and metabolism produkter, - fabrazyme er indiceret til langsigtet enzymudskiftningsterapi hos patienter med en bekræftet diagnose af fabrys sygdom (a-galactosidase-a-mangel).

Den Europæiske Union - dansk - EMA (European Medicines Agency)

astrazeneca ab - a/darwin/9/2021 (h3n2) - like strain (a/norway/16606/2021, medi 355293) / a/victoria/2570/2019 (h1n1)pdm09 - like strain (a/victoria/1/2020, medi 340505) / b/austria/1359417/2021 - like strain (b/austria/1359417/2021, medi 355292) / b/phuket/3073/2013 - like strain (b/phuket/3073/2013, medi 306444) - influenza, human - vacciner mod influenza, influenza, levende, svækkede - prophylaxis of influenza in children and adolescents from 24 months to less than 18 years of age. brug af fluenz tetra bør baseres på officielle anbefalinger.